This mRNA vaccine could potentially prevent the deadliest form of skin cancer
Summary
Companies Moderna and Merck developed a personalized mRNA vaccine combined with the drug Keytruda. This treatment helped reduce the return and spread of melanoma, a serious type of skin cancer, in patients at high risk.Key Facts
- Moderna and Merck are drug manufacturers working on cancer treatments.
- They created a personalized vaccine using mRNA technology.
- The vaccine was used together with the drug Keytruda.
- The treatment focused on melanoma, the deadliest form of skin cancer.
- It showed signs of reducing the cancer’s return and spreading.
- The vaccine is tailored to each patient’s cancer.
- The information comes from doctors involved in the research, including Dr. Jon LaPook and Dr. Janice Mehnert.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
